跳至主要内容
临床试验/NL-OMON22222
NL-OMON22222招募中不适用

Hypersensitivity in eosinophilic esophagitis

Amsterdam UMC, Location AMC0 个研究点目标入组 17 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
17

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

入选标准

  • Previous diagnosis of active EoE confirmed by histopathology e.g. presence of >15 eosinophilic granulocytes per high power field (hpf) in esophageal biopsies
  • - Written informed consent
  • - Age 18-75 years

排除标准

  • - Any form of treatment for EoE (topical corticosteroids, PPI or dietary treatment) in the month preceding the study
  • - ASA class III, IV or V
  • - The need for pain medication 24 hours before the visit

研究者

发起方
Amsterdam UMC, Location AMC

相似试验

Hypersensitivity in eosinophilic esophagitis | 临床试验